摘要
Objective To compare and analyze the clinical efficacy and safety of ferric derisomaltose injection(FDI)and iron sucrose injection(ISI)in the treatment of iron deficiency anemia(IDA)in patients with inflammatory bowel disease(IBD).Methods From January 1,2023 to August 31,2024,89 IBD patients complicated with IDA hospitalized and treated at the Department of Gastroenterology,Tenth People's Hospital of Tongji University were enrolled and divided into the FDI group(44 cases)and ISI group(45 cases).
